| 2025 | 2024 | 2023 | 2022 | 2021 | 2016 | 2015 | 2014 | 2013 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 24,8 M € | +3.6% | 23,9 M € | -21.2% | 30,4 M € | +10.2% | 27,6 M € | +0.4% | 27,4 M € | +30.4% | 21,0 M € | +10.7% | 19,0 M € | +15.2% | 16,5 M € | -5.7% | 17,5 M € | +8.8% | 16,1 M € | -3.8% | 16,7 M € | +13.5% | 14,7 M € | +11.2% | 13,2 M € | +34.3% | 9,9 M € | |
| EBITDA | 4,0 M € | -4.3% | 4,2 M € | -44.2% | 7,4 M € | +43.5% | 5,2 M € | -14.3% | 6,0 M € | +51.4% | 4,0 M € | -17.1% | 4,8 M € | +40.0% | 3,4 M € | -32.7% | 5,1 M € | +7.1% | 4,8 M € | -3.9% | 5,0 M € | +62.3% | 3,1 M € | -7.9% | 3,3 M € | -6.4% | 3,6 M € | |
| Operating profit | 2,3 M € | +0.5% | 2,3 M € | -58.1% | 5,4 M € | +80.3% | 3,0 M € | -22.4% | 3,8 M € | +195.4% | 1,3 M € | -41.6% | 2,2 M € | +148.4% | 894,2 k € | -65.6% | 2,6 M € | +1.4% | 2,6 M € | -19.6% | 3,2 M € | +109.5% | 1,5 M € | -25.4% | 2,0 M € | -28.5% | 2,9 M € | |
| Profit/loss | 1,8 M € | +4.6% | 1,7 M € | -55.6% | 3,9 M € | +93.8% | 2,0 M € | -24.9% | 2,7 M € | +250.3% | 761,5 k € | -43.7% | 1,4 M € | +131.1% | 585,6 k € | -64.3% | 1,6 M € | -35.4% | 2,5 M € | +49.8% | 1,7 M € | +160.9% | 649,2 k € | +16.7% | 556,3 k € | -66.8% | 1,7 M € | |
| Equity | 21,1 M € | +9.3% | 19,3 M € | +9.8% | 17,6 M € | +28.3% | 13,7 M € | +17.1% | 11,7 M € | -12.2% | 13,3 M € | +5.9% | 12,6 M € | +15.6% | 10,9 M € | +5.5% | 10,3 M € | +0.4% | 10,3 M € | +33.2% | 7,7 M € | +27.7% | 6,1 M € | +11.4% | 5,4 M € | -23.1% | 7,1 M € | |
| Total assets | 28,3 M € | +8.5% | 26,0 M € | -2.0% | 26,6 M € | +24.0% | 21,4 M € | -6.5% | 22,9 M € | -8.9% | 25,1 M € | +29.7% | 19,4 M € | +12.6% | 17,2 M € | -1.6% | 17,5 M € | -10.3% | 19,5 M € | -2.4% | 20,0 M € | +18.2% | 16,9 M € | +10.4% | 15,3 M € | -20.8% | 19,3 M € | |
| Cash | 32,5 k € | +8.7% | 29,9 k € | -78.5% | 138,7 k € | -3.2% | 143,3 k € | -23.4% | 187,0 k € | -85.7% | 1,3 M € | +46.2% | 892,3 k € | -65.2% | 2,6 M € | +2533.9% | 97,4 k € | -97.9% | 4,6 M € | +2576.4% | 170,3 k € | -35.2% | 262,9 k € | +170.0% | 97,4 k € | -83.0% | 574,2 k € | |
| Debts | 7,1 M € | +6.3% | 6,7 M € | -25.1% | 9,0 M € | +16.4% | 7,7 M € | -30.9% | 11,1 M € | -0.6% | 11,2 M € | +93.9% | 5,8 M € | +2.5% | 5,6 M € | -12.2% | 6,4 M € | -14.3% | 7,5 M € | -24.9% | 10,0 M € | +11.9% | 8,9 M € | +18.3% | 7,5 M € | -15.0% | 8,9 M € | |
| Staff | 102 | 116,6 | 123,5 | 120,1 | 121,4 | 103,8 | 104,8 | 104,3 | 109,3 | 109,7 | 112 | 111,9 | 103 | 99,9 | ||||||||||||||
Private limited company · Seraing · incorporated on 17/08/1945 · 102,0 ETP
Private limited company profitable and well capitalised. Cash position rising (+8.7%).
Solid counterparty for a standard engagement.
Arysta LifeScience Ougrée Production is a Private limited company incorporated in 1945. Its main activity is: Manufacture of fertilisers and nitrogen compounds. Its registered office is in Seraing. It employs on average 102,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette